Literature DB >> 9607608

ICAM-1 and VCAM-1 expression induced by TNF-alpha are inhibited by a glutathione peroxidase mimic.

P d'Alessio1, M Moutet, E Coudrier, S Darquenne, J Chaudiere.   

Abstract

Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) are respectively involved in the endothelial recruitment of neutrophils, and in that of lymphocytes or tumor cells, in response to specific signals. We have used the glutathione peroxidase (GPx) mimic BXT-51072 to assess the possibility that endogenous hydroperoxides play a role in the tumor necrosis factor-alpha (TNFalpha)-induced expression of ICAM-1 and VCAM-1 by monolayers of human endothelial cells. The GPx mimic BXT-51072 strongly inhibits the TNFalpha-induced and cycloheximide-sensitive expression of ICAM-1 and VCAM-1. It also inhibits the TNFalpha-induced reorganization of the actin network and the associated formation of stress fibers. Actin reorganization induced by cytochalasin D treatment did not inhibit ICAM-1 expression. Our results are compatible with specific and synergistic effects of endogenous hydroperoxides on the biosynthesis and processing of cell adhesion molecules and cytoskeleton components.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607608     DOI: 10.1016/s0891-5849(97)00396-1

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  9 in total

1.  Glutathione peroxidase-1 deficiency augments proinflammatory cytokine-induced redox signaling and human endothelial cell activation.

Authors:  Edith Lubos; Neil J Kelly; Scott R Oldebeken; Jane A Leopold; Ying-Yi Zhang; Joseph Loscalzo; Diane E Handy
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

2.  Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase.

Authors:  David J Greenblatt; Diane E Peters; Lauren E Oleson; Jerold S Harmatz; Malcolm W MacNab; Noah Berkowitz; Miguel A Zinny; Michael H Court
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

Review 3.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

4.  Circulating adhesion molecules in patients with Keshan disease and their relationship with Coxsackie B virus infection.

Authors:  Congsheng Li; Xiaolin Niu; Cong Lei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

5.  Ebselen improves ischemia-reperfusion injury after rat lung transplantation.

Authors:  Jürg Hamacher; Uz Stammberger; Elvira Weber; Rudolf Lucas; Albrecht Wendel
Journal:  Lung       Date:  2009-02-07       Impact factor: 2.584

Review 6.  Targeting oxidative stress in disease: promise and limitations of antioxidant therapy.

Authors:  Henry Jay Forman; Hongqiao Zhang
Journal:  Nat Rev Drug Discov       Date:  2021-06-30       Impact factor: 84.694

7.  Golgi-independent routes support protein disulfide isomerase externalization in vascular smooth muscle cells.

Authors:  Thaís L S Araujo; Carolina G Fernandes; Francisco R M Laurindo
Journal:  Redox Biol       Date:  2017-05-03       Impact factor: 11.799

8.  Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.

Authors:  Claudia-Gabriela Mitrofan; Sarah L Appleby; Gerard B Nash; Ziad Mallat; Edwin R Chilvers; Paul D Upton; Nicholas W Morrell
Journal:  J Biol Chem       Date:  2017-06-23       Impact factor: 5.157

Review 9.  The Role of Nrf2 in Cellular Innate Immune Response to Inflammatory Injury.

Authors:  Jiyoung Kim; Young-Joon Surh
Journal:  Toxicol Res       Date:  2009-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.